A new instrument for the assessment of patient-defined benefit in the treatment of allergic rhinitis.
Related Research units
Abstract
Allergic rhinitis (AR) is a common disease that affects health-related quality of life (HRQoL). Current and future health policy demands the assessment of patient-relevant treatment benefit for evaluation of treatments.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 5 |
| ISSN | 0105-4538 |
| Publication status | Published - 2011 |
| pubmed | 21121931 |
|---|
